ARTICLE | Clinical News
Genentech preclinical data
March 17, 2008 7:00 AM UTC
HhAntag, a signal transduction inhibitor with demonstrated anti-tumor activity in adult transgenic mice with medulloastoma, caused serious, permanent impairments to developing bones in 10 to 14-day ol...